Post-marketing liver injury reports lead to Tysabri PI update

Article

Liver injury warnings added to natalizumab prescribing information.

Reports of markedly elevated serum hepatic enzymes and elevated total bilirubin in patients receiving natalizumab (

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.